- call +1-201-465-4211
- email sales@mrinsights.biz
Alpha-glucosidase is an enzyme that is inhibited by alpha-glucosidase inhibitor drugs. Alpha-glucosidase helps in absorption of carbohydrates by breaking down carbohydrates into tiny sugar molecules such as glucose. The inhibition is reversible, and competitive inhibition. Alpha-glucosidase inhibitor drugs help in delaying glucose absorption and slow the digestion of carbohydrates. This results in lower rise of glucose in the blood after meals and remains effective throughout the day.
Scope of the Report:
Acarbose is the most widely prescribed of the three currently available (Acarbose, Miglitol, and Voglibose) alpha‐glucosidase inhibitors and has been used in the management of hyperglycemia for years.
The worldwide market for Alpha Glucosidase Inhibitors is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Alpha Glucosidase Inhibitors in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Pfizer
Bayer pharma
Takeda
Sun pharma
Glenmark pharma
Torrent
Hexalag
Unichem
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Dumping Syndrome
Type 2 Diabetes
Market Segment by Applications, can be divided into
Online Pharmacies
Retail Pharmacies
Hospital Pharmacies
There are 15 Chapters to deeply display the global Alpha Glucosidase Inhibitors market.
Chapter 1, to describe Alpha Glucosidase Inhibitors Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Alpha Glucosidase Inhibitors, with sales, revenue, and price of Alpha Glucosidase Inhibitors, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Alpha Glucosidase Inhibitors, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Alpha Glucosidase Inhibitors market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Alpha Glucosidase Inhibitors sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Alpha Glucosidase Inhibitors Introduction
1.2 Market Analysis by Type
1.2.1 Dumping Syndrome
1.2.2 Type 2 Diabetes
1.3 Market Analysis by Applications
1.3.1 Online Pharmacies
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Alpha Glucosidase Inhibitors Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Alpha Glucosidase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bayer pharma
2.2.1 Business Overview
2.2.2 Alpha Glucosidase Inhibitors Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bayer pharma Alpha Glucosidase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Takeda
2.3.1 Business Overview
2.3.2 Alpha Glucosidase Inhibitors Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Takeda Alpha Glucosidase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sun pharma
2.4.1 Business Overview
2.4.2 Alpha Glucosidase Inhibitors Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sun pharma Alpha Glucosidase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Glenmark pharma
2.5.1 Business Overview
2.5.2 Alpha Glucosidase Inhibitors Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Glenmark pharma Alpha Glucosidase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Torrent
2.6.1 Business Overview
2.6.2 Alpha Glucosidase Inhibitors Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Torrent Alpha Glucosidase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Hexalag
2.7.1 Business Overview
2.7.2 Alpha Glucosidase Inhibitors Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Hexalag Alpha Glucosidase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Unichem
2.8.1 Business Overview
2.8.2 Alpha Glucosidase Inhibitors Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Unichem Alpha Glucosidase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Alpha Glucosidase Inhibitors Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Alpha Glucosidase Inhibitors Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Alpha Glucosidase Inhibitors Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Alpha Glucosidase Inhibitors Manufacturer Market Share in 2017
3.3.2 Top 6 Alpha Glucosidase Inhibitors Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Alpha Glucosidase Inhibitors Market Analysis by Regions
4.1 Global Alpha Glucosidase Inhibitors Sales, Revenue and Market Share by Regions
4.1.1 Global Alpha Glucosidase Inhibitors Sales and Market Share by Regions (2013-2018)
4.1.2 Global Alpha Glucosidase Inhibitors Revenue and Market Share by Regions (2013-2018)
4.2 North America Alpha Glucosidase Inhibitors Sales and Growth Rate (2013-2018)
4.3 Europe Alpha Glucosidase Inhibitors Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Alpha Glucosidase Inhibitors Sales and Growth Rate (2013-2018)
4.5 South America Alpha Glucosidase Inhibitors Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Alpha Glucosidase Inhibitors Sales and Growth Rate (2013-2018)
5 North America Alpha Glucosidase Inhibitors by Countries
5.1 North America Alpha Glucosidase Inhibitors Sales, Revenue and Market Share by Countries
5.1.1 North America Alpha Glucosidase Inhibitors Sales and Market Share by Countries (2013-2018)
5.1.2 North America Alpha Glucosidase Inhibitors Revenue and Market Share by Countries (2013-2018)
5.2 United States Alpha Glucosidase Inhibitors Sales and Growth Rate (2013-2018)
5.3 Canada Alpha Glucosidase Inhibitors Sales and Growth Rate (2013-2018)
5.4 Mexico Alpha Glucosidase Inhibitors Sales and Growth Rate (2013-2018)
6 Europe Alpha Glucosidase Inhibitors by Countries
6.1 Europe Alpha Glucosidase Inhibitors Sales, Revenue and Market Share by Countries
6.1.1 Europe Alpha Glucosidase Inhibitors Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Alpha Glucosidase Inhibitors Revenue and Market Share by Countries (2013-2018)
6.2 Germany Alpha Glucosidase Inhibitors Sales and Growth Rate (2013-2018)
6.3 UK Alpha Glucosidase Inhibitors Sales and Growth Rate (2013-2018)
6.4 France Alpha Glucosidase Inhibitors Sales and Growth Rate (2013-2018)
6.5 Russia Alpha Glucosidase Inhibitors Sales and Growth Rate (2013-2018)
6.6 Italy Alpha Glucosidase Inhibitors Sales and Growth Rate (2013-2018)
7 Asia-Pacific Alpha Glucosidase Inhibitors by Countries
7.1 Asia-Pacific Alpha Glucosidase Inhibitors Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Alpha Glucosidase Inhibitors Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Alpha Glucosidase Inhibitors Revenue and Market Share by Countries (2013-2018)
7.2 China Alpha Glucosidase Inhibitors Sales and Growth Rate (2013-2018)
7.3 Japan Alpha Glucosidase Inhibitors Sales and Growth Rate (2013-2018)
7.4 Korea Alpha Glucosidase Inhibitors Sales and Growth Rate (2013-2018)
7.5 India Alpha Glucosidase Inhibitors Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Alpha Glucosidase Inhibitors Sales and Growth Rate (2013-2018)
8 South America Alpha Glucosidase Inhibitors by Countries
8.1 South America Alpha Glucosidase Inhibitors Sales, Revenue and Market Share by Countries
8.1.1 South America Alpha Glucosidase Inhibitors Sales and Market Share by Countries (2013-2018)
8.1.2 South America Alpha Glucosidase Inhibitors Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Alpha Glucosidase Inhibitors Sales and Growth Rate (2013-2018)
8.3 Argentina Alpha Glucosidase Inhibitors Sales and Growth Rate (2013-2018)
8.4 Colombia Alpha Glucosidase Inhibitors Sales and Growth Rate (2013-2018)
9 Middle East and Africa Alpha Glucosidase Inhibitors by Countries
9.1 Middle East and Africa Alpha Glucosidase Inhibitors Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Alpha Glucosidase Inhibitors Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Alpha Glucosidase Inhibitors Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Alpha Glucosidase Inhibitors Sales and Growth Rate (2013-2018)
9.3 UAE Alpha Glucosidase Inhibitors Sales and Growth Rate (2013-2018)
9.4 Egypt Alpha Glucosidase Inhibitors Sales and Growth Rate (2013-2018)
9.5 Nigeria Alpha Glucosidase Inhibitors Sales and Growth Rate (2013-2018)
9.6 South Africa Alpha Glucosidase Inhibitors Sales and Growth Rate (2013-2018)
10 Global Alpha Glucosidase Inhibitors Market Segment by Type
10.1 Global Alpha Glucosidase Inhibitors Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Alpha Glucosidase Inhibitors Sales and Market Share by Type (2013-2018)
10.1.2 Global Alpha Glucosidase Inhibitors Revenue and Market Share by Type (2013-2018)
10.2 Dumping Syndrome Sales Growth and Price
10.2.1 Global Dumping Syndrome Sales Growth (2013-2018)
10.2.2 Global Dumping Syndrome Price (2013-2018)
10.3 Type 2 Diabetes Sales Growth and Price
10.3.1 Global Type 2 Diabetes Sales Growth (2013-2018)
10.3.2 Global Type 2 Diabetes Price (2013-2018)
11 Global Alpha Glucosidase Inhibitors Market Segment by Application
11.1 Global Alpha Glucosidase Inhibitors Sales Market Share by Application (2013-2018)
11.2 Online Pharmacies Sales Growth (2013-2018)
11.3 Retail Pharmacies Sales Growth (2013-2018)
11.4 Hospital Pharmacies Sales Growth (2013-2018)
12 Alpha Glucosidase Inhibitors Market Forecast (2018-2023)
12.1 Global Alpha Glucosidase Inhibitors Sales, Revenue and Growth Rate (2018-2023)
12.2 Alpha Glucosidase Inhibitors Market Forecast by Regions (2018-2023)
12.2.1 North America Alpha Glucosidase Inhibitors Market Forecast (2018-2023)
12.2.2 Europe Alpha Glucosidase Inhibitors Market Forecast (2018-2023)
12.2.3 Asia-Pacific Alpha Glucosidase Inhibitors Market Forecast (2018-2023)
12.2.4 South America Alpha Glucosidase Inhibitors Market Forecast (2018-2023)
12.2.5 Middle East and Africa Alpha Glucosidase Inhibitors Market Forecast (2018-2023)
12.3 Alpha Glucosidase Inhibitors Market Forecast by Type (2018-2023)
12.3.1 Global Alpha Glucosidase Inhibitors Sales Forecast by Type (2018-2023)
12.3.2 Global Alpha Glucosidase Inhibitors Market Share Forecast by Type (2018-2023)
12.4 Alpha Glucosidase Inhibitors Market Forecast by Application (2018-2023)
12.4.1 Global Alpha Glucosidase Inhibitors Sales Forecast by Application (2018-2023)
12.4.2 Global Alpha Glucosidase Inhibitors Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Alpha Glucosidase Inhibitors Picture
Table Product Specifications of Alpha Glucosidase Inhibitors
Figure Global Sales Market Share of Alpha Glucosidase Inhibitors by
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
